Meanwhile, miRNA-125a was reported to have oncogenic potential, which may promote the progression and invasion of gastric cancer through the regulation of EphA2, TAZ, and TEAD2 and myeloma progression through a reduction in DIS3 expression level [63,64]. This evidence concerns the gene DIS3 and plasma cell myeloma.